Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c06205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Mina Yamane und 18 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Synthetic Organic Chemistry Lab, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Oxygen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Kumamoto University, Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology.
Abstract (Originalsprache)
The escalating global trend of aging populations has brought attention to the rising prevalence of late-onset amyloid disorders. Among them, amyloid transthyretin (ATTR) amyloidosis presents a growing area of unmet medical needs. While current treatment modalities have demonstrated efficacy in preventing or delaying amyloid generation, methodology to selectively modify and neutralize existing amyloid burdens remains inadequately addressed, leaving the fundamental irreversibility and hence the fatality of these conditions, a long-standing medical challenge. Here, we report the first demonstration of therapeutic efficacy in ATTR amyloidosis via dynamic control of ATTR aggregation and toxicity, enabled by small-molecule organophotocatalysis. Selective incorporation of hydrophilic oxygen atoms into the hydrophobic amyloid core reshapes the aggregation landscape, neutralizing proteotoxicity, and mitigating cellular damage. Additionally, this targeted covalent modification significantly reduces in vivo ROS levels, correlating with the observed therapeutic effects in Caenorhabditis elegans, the only experimental model replicating key clinical manifestations of the disease. Docking simulations elucidated the molecular basis of catalyst performance, providing the foundational blueprint for amyloid-neutralizing organophotocatalysis. Collectively, this study provides a scalable approach to overcoming a persistent barrier in amyloidosis therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Synthetic Organic Chemistry Lab, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan.
- Graduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
- Graduate School of Pharmaceutical Sciences, Neuropathology and Neuroscience Lab, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.
- Graduate School of Innovative Life Science, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
- School of Medicine, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 862-8556, Japan.
ORCID-Profile: Mina Yamane, Genki Kudo, Harunobu Mitsunuma, Mineyuki Mizuguchi, Shigehiro A Kawashima, Hironori Kaji, Takatsugu Hirokawa, Motomu Kanai
Förderung
- Kumamoto University
- Ministry of Education, Culture, Sports, Science and Technology
- Core Research for Evolutional Science and Technology
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Yamane, M., Umeda, H., Toyobe, M., Iwai, A., Ishihara, K., Kudo, G., Mitsunuma, H., Hori, Y., Tomita, T., Mizuguchi, M., Okada, M., Ueda, M., Ando, Y., Kawashima, S. A., Sohma, Y., Kaji, H., Hirokawa, T., Yamanaka, K., & Kanai, M. (2025). Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c06205
Vancouver
Yamane M, Umeda H, Toyobe M, Iwai A, Ishihara K, Kudo G, et al. Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c06205
BibTeX
@article{Yamane2025,
author = {Yamane, Mina and Umeda, Hiroki and Toyobe, Moe and Iwai, Atsushi and Ishihara, Kuraudo and Kudo, Genki and Mitsunuma, Harunobu and Hori, Yukiko and Tomita, Taisuke and Mizuguchi, Mineyuki and Okada, Masamitsu and Ueda, Mitsuharu and Ando, Yukio and Kawashima, Shigehiro A and Sohma, Youhei and Kaji, Hironori and Hirokawa, Takatsugu and Yamanaka, Kunitoshi and Kanai, Motomu},
title = {Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c06205}
}
EUVIMED